TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32701140

Group type: EXPERIMENTAL
Intervention: Standard-of-care neoadjuvant therapy consisting of taxane treatment followed by doxorubicin and cyclophosphamide.
Number of subjects: 950

Group type: COMPARATOR
Intervention: Control therapy (taxane treatment without investigational agents).
Number of subjects: 950
Study: 36282530

Group type: EXPERIMENTAL
Intervention: risankizumab 150 mg
Number of subjects: 964

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 964
Study: 33720373

Group type: EXPERIMENTAL
Intervention: Brief Behavioral Therapy (BBT)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Assisted Referral to Community Outpatient Mental Health Care (ARC)
Number of subjects: 185
Study: 32584180

Group type: EXPERIMENTAL
Intervention: butorphanol tartrate (5 mg/kg)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: But‐P407 (12.5 mg/kg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: P407
Number of subjects: 13
Study: 35380376

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 µg/kg) with ketamine (0.5 mg/kg) administered over 10 min followed by a maintenance dose of Dexmedetomidine (0.2‐0.8 µg/kg/h)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Dexmedetomidine (1 µg/kg) administered over 10 min followed by a maintenance dose
Number of subjects: 30
Study: 33641108

Group type: EXPERIMENTAL
Intervention: Cohort study with 7-day Holter ECGs
Number of subjects: 795

Group type: COMPARATOR
Intervention: Case-control study with clinical prediction model
Number of subjects: 795
Study: 33016783

Group type: EXPERIMENTAL
Intervention: AryoTrust® (6 mg/kg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Herceptin® (6 mg/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: AryoTrust®
Number of subjects: 60

Group type: COMPARATOR
Intervention: Herceptin®
Number of subjects: 60
Study: 35969460

Group type: EXPERIMENTAL
Intervention: Combo condition (interactive website with stigma-related content)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Stigma condition (noninteractive website with stigma-related content)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Interact condition (interactive website without stigma-related content)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Control condition (noninteractive website without stigma-related content)
Number of subjects: 263
Study: 33630936

Group type: EXPERIMENTAL
Intervention: Poor glycemic control
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Being female
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Duration of diabetes >8 years
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Presence of diabetes complications
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Negligence of blood glucose test at home
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Poor self-care behavior
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Poor self-efficacy
Number of subjects: 423
Study: 34333792

Group type: EXPERIMENTAL
Intervention: Social justice and race equity training (n = 49)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Training attendees (n = 23)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group (n = 50)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Training condition (attendees)
Number of subjects: 99
Study: 32812846

Group type: EXPERIMENTAL
Intervention: VR environments at 0 ft (VR0)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: VR environments at 40 ft (VR40)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: VR environments at 120 ft (VR120)
Number of subjects: 19

Group type: COMPARATOR
Intervention: No VR
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Simulation Sickness Questionnaire (SSQ)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Presence Questionnaire (PQ)
Number of subjects: 19
Study: 35545356

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT) as an addition to usual care
Number of subjects: 33

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 33
Study: 32297556

Group type: EXPERIMENTAL
Intervention: Consistent HCV infection confirmed by both medical records and self-reports
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Discrepant HCV results
Number of subjects: 181
Study: 36360712

Group type: EXPERIMENTAL
Intervention: Survey participation
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Focus group discussions
Number of subjects: 102
Study: 32673171

Group type: EXPERIMENTAL
Intervention: sorafenib
Number of subjects: 83

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 83
Study: 35027515

Group type: EXPERIMENTAL
Intervention: Goal-directed therapy (GDT) protocol using DCO2 and SCvo2
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional goal-directed care (control group)
Number of subjects: 100
Study: 33597333

Group type: EXPERIMENTAL
Intervention: Continuous Thoracic Epidural Analgesia (TEA)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Continuous Paravertebral Block (PVB)
Number of subjects: 86
Study: 33104651

Group type: EXPERIMENTAL
Intervention: Hybrid Fabry‐Perot fiber‐optic sensor
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Another sensor in the same batch
Number of subjects: 3
Study: 32394780

Group type: EXPERIMENTAL
Intervention: ITP group (intensive training program)
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: ITP+ group (intensive training program and educational video)
Number of subjects: 390

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 390
Study: 32000140

Group type: EXPERIMENTAL
Intervention: Vertical resisted sprint (VRS)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Horizontal resisted sprint
Number of subjects: 48

Group type: COMPARATOR
Intervention: Combined resisted sprint
Number of subjects: 48

Group type: COMPARATOR
Intervention: Unresisted sprint
Number of subjects: 48
Study: 33345953

Group type: EXPERIMENTAL
Intervention: 100% oxygen at 10 L/min until delivery
Number of subjects: 117

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 117
Study: 34117383

Group type: EXPERIMENTAL
Intervention: Tecnis +2.75 D (ZKB00) (MIOL Group)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Tecnis Symfony (ZXR00) (EDOF Group)
Number of subjects: 29
Study: 33177149

Group type: EXPERIMENTAL
Intervention: EBP training
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Mobile applications usage
Number of subjects: 110
Study: 36171701

Group type: EXPERIMENTAL
Intervention: Orem's Self‐Care Deficit Theory (OSCDT) based education and telephone follow‐ups
Number of subjects: 47

Group type: COMPARATOR
Intervention: Routine nursing care (Control)
Number of subjects: 47
Study: 34521493

Group type: EXPERIMENTAL
Intervention: Diabetes self-management education (DSME)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 77
Study: 36236307

Group type: EXPERIMENTAL
Intervention: Energy Drink (ED)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 35222905

Group type: EXPERIMENTAL
Intervention: Whole-body photobiomodulation (PBM) therapy programme
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 32590517

Group type: EXPERIMENTAL
Intervention: Supercharge end-to-side anterior interosseous nerve-to-ulnar motor nerve transfer
Number of subjects: 42
Study: 36435547

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy (IPT)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Relaxation Therapy (RT)
Number of subjects: 92

Group type: COMPARATOR
Intervention: All treatment groups (PE, IPT, RT)
Number of subjects: 92
Study: 34472231

Group type: EXPERIMENTAL
Intervention: Enteral recombinant human insulin (400 μU/ml mixed with enteral feeding)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo added to formula
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Enteral recombinant human insulin
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33

Group type: COMPARATOR
Intervention: Enteral recombinant human insulin and Placebo
Number of subjects: 33
Study: 36307891

Group type: EXPERIMENTAL
Intervention: Leader education program
Number of subjects: 148

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 148
Study: 33153829

Group type: EXPERIMENTAL
Intervention: Outpatient counseling plus vouchers for attendance (VOU)
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Outpatient counseling plus text reminders (REM)
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Outpatient counseling plus vouchers and text reminders (REM + VOU)
Number of subjects: 460

Group type: COMPARATOR
Intervention: Standard outpatient counseling only (STD)
Number of subjects: 460
Study: 32438316

Group type: EXPERIMENTAL
Intervention: Simulation training in research design
Number of subjects: 0
Study: 36045446

Group type: EXPERIMENTAL
Intervention: Myofascial release protocol applied to the cervical spine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo light touch protocol
Number of subjects: 0
Study: 32461138

Group type: EXPERIMENTAL
Intervention: High-dose vitamin D (25,000 IU weekly for 26 weeks)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 143
Study: 35985201

Group type: EXPERIMENTAL
Intervention: Direct care by co-located psychiatrists
Number of subjects: 191

Group type: COMPARATOR
Intervention: Collaborative care (primary care clinicians supported by psychiatrists)
Number of subjects: 191
Study: 35212487

Group type: EXPERIMENTAL
Intervention: XELOX
Number of subjects: 448

Group type: COMPARATOR
Intervention: EOX
Number of subjects: 448
Study: 35693272

Group type: EXPERIMENTAL
Intervention: Laparoscopy combined with choledochoscopy
Number of subjects: 86

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 86
Study: 33606419

Group type: EXPERIMENTAL
Intervention: Predetermined volumes of a feeding-drink (Nutricia Nutridrink) between 50 and 400 ml
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: New model using the antral cross-sectional area in the right-lateral decubitus position
Number of subjects: 72
Study: 33780930

Group type: EXPERIMENTAL
Intervention: Experimental group increased TWI to 3.7 L for males and 2.7 L for females for 14 days.
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group maintained habitual low TWI.
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Both groups (experimental and control) measured for changes in blood volume (BV) and total body water (TBW).
Number of subjects: 23
Study: 35429718

Group type: EXPERIMENTAL
Intervention: SAFMEDS intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study: 32731750

Group type: EXPERIMENTAL
Intervention: Mobilisation with movement and usual care (exercise and moist heat)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 40
Study: 615920826

Group type: EXPERIMENTAL
Intervention: Besivance (3 times a day for 10 days)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Polytrim (3 times a day for 10 days)
Number of subjects: 24
Study: 36054314

Group type: EXPERIMENTAL
Intervention: RLRL-RLRL group
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: SVS-RLRL group
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: RLRL-SVS group
Number of subjects: 114

Group type: COMPARATOR
Intervention: SVS-SVS group
Number of subjects: 114
Study: 34132739

Group type: EXPERIMENTAL
Intervention: Autologous CoNS‐AM+ (n = 5)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Vehicle (n = 6)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Autologous CoNS‐AM+
Number of subjects: 11

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 11
Study: 35587843

Group type: EXPERIMENTAL
Intervention: High-intensity NPPV
Number of subjects: 24

Group type: COMPARATOR
Intervention: Low-intensity NPPV
Number of subjects: 24
Study: 34939397

Group type: EXPERIMENTAL
Intervention: Herb-partitioned moxibustion combined with electroacupuncture (43 ± 1) ℃, 3 times per week for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group received herb-partitioned moxibustion (37 ± 1) ℃ and sham electroacupuncture
Number of subjects: 60
Study: 34737096

Group type: EXPERIMENTAL
Intervention: Navigation group (NG) - 2-dimensional navigation guidance used for vertebral body screw placement.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (CG) - No navigation guidance used for vertebral body screw placement.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (NG and CG)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Navigation group (NG)
Number of subjects: 40
Study: 34126130

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 3991

Group type: COMPARATOR
Intervention: Prasugrel
Number of subjects: 3991
Study: 32988827

Group type: EXPERIMENTAL
Intervention: Ceftolozane/tazobactam (C/T)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Meropenem
Number of subjects: 4
Study: 34232470

Group type: EXPERIMENTAL
Intervention: c-tDCS
Number of subjects: 21

Group type: COMPARATOR
Intervention: SHAM stimulation
Number of subjects: 21
Study: 33370228

Group type: EXPERIMENTAL
Intervention: Umbilical cord blood (UCB) transfusion
Number of subjects: 1651
Study: 33184928

Group type: EXPERIMENTAL
Intervention: Tai Chi Chuan (TCC) exercise, 35-40 min/session, twice a week for 12 weeks
Number of subjects: 20
Study: 32590491

Group type: EXPERIMENTAL
Intervention: Perceived overqualification
Number of subjects: 1456

Group type: EXPERIMENTAL
Intervention: Turnover intention
Number of subjects: 1456
Study: 35844026

Group type: EXPERIMENTAL
Intervention: Anlotinib
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 33819215

Group type: EXPERIMENTAL
Intervention: Biodex balance training and traditional exercise programme
Number of subjects: 48

Group type: COMPARATOR
Intervention: Traditional exercise programme
Number of subjects: 48
Study: 35727681

Group type: EXPERIMENTAL
Intervention: 0.07% CPC (Vitis CPC Protect) mouthwash
Number of subjects: 118

Group type: COMPARATOR
Intervention: colored distilled water (placebo)
Number of subjects: 118
Study: 32580771

Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Artesunate-amodiaquine (ASAQ)
Number of subjects: 421
Study: 35886495

Group type: EXPERIMENTAL
Intervention: Environmental commitment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Environmental commitment with high social norms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anticipated pride and anticipated guilt
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Social norms
Number of subjects: 0
Study: 32761620

Group type: EXPERIMENTAL
Intervention: Skin tests (STs) for metronidazole/ornidazole
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Single-blind placebo-controlled drug provocation tests (SBPCDPTs)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Basophil activation test (BAT) for metronidazole
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Basophil activation test (BAT) for ornidazole
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: No cross-reactivity observed between metronidazole and ornidazole according to in vivo tests.
Number of subjects: 49
Study: 35357704

Group type: EXPERIMENTAL
Intervention: Guidewire group (using a SWARTZ sheath and a Brockenbrough needle with a 0.014‐inch coronary guidewire)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Contrast group (using standard devices and injecting contrast to confirm needle-tip position)
Number of subjects: 200
Study: 32777710

Group type: EXPERIMENTAL
Intervention: Lady Health Worker (LHW) facilitated community engagement and early diagnosis, stabilization and referral of women with preeclampsia
Number of subjects: 39446
Study: 33883152

Group type: COMPARATOR
Intervention: Wait-and-see approach
Number of subjects: 15
Study: 32886666

Group type: EXPERIMENTAL
Intervention: Change Agents (CAs)
Number of subjects: 458

Group type: COMPARATOR
Intervention: NMs (social network members)
Number of subjects: 458
Study: 616782744

Group type: EXPERIMENTAL
Intervention: Metoprolol plus Trimetazidine (Met+Tri)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control (no Met+Tri)
Number of subjects: 200
Study: 36029132

Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (grapefruit juice)
Number of subjects: 21
Study: 33339752

Group type: EXPERIMENTAL
Intervention: Graduated medical elastic thigh compression stocking for 14 days
Number of subjects: 44

Group type: COMPARATOR
Intervention: Standard treatment for 14 days
Number of subjects: 44
Study: 33031270

Group type: EXPERIMENTAL
Intervention: 300 mg of VASO6 (green tea extract)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 8 g L-citrulline malate and 3 g L-arginine hydrochloride
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 35113311

Group type: EXPERIMENTAL
Intervention: Selective laser trabeculoplasty (SLT)
Number of subjects: 21
Study: 33170969

Group type: EXPERIMENTAL
Intervention: Goal-directed support including vasopressor use
Number of subjects: 79

Group type: COMPARATOR
Intervention: Traditional volume-based support
Number of subjects: 79

Group type: COMPARATOR
Intervention: Traditional volume-based support (soft tissue flaps)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Goal-directed support including vasopressor use (soft tissue flaps)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Traditional volume-based support (bony flaps)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Goal-directed support including vasopressor use (bony flaps)
Number of subjects: 79
Study: 36155238

Group type: EXPERIMENTAL
Intervention: Emotional working memory training (EWMT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 40
Study: 32723859

Group type: EXPERIMENTAL
Intervention: Portable Oxygen Concentrator (POC)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Portable Compressed Oxygen Cylinder
Number of subjects: 30
Study: 34011710

Group type: EXPERIMENTAL
Intervention: Postoperative follow-up at Day 3-7 and Day 25-30 after a mandatory Day 0 examination
Number of subjects: 848

Group type: COMPARATOR
Intervention: Postoperative follow-up directly at Day 25-30 after a mandatory Day 0 examination
Number of subjects: 848
Study: 33263954

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 35131452

Group type: EXPERIMENTAL
Intervention: Atezolizumab plus vemurafenib plus cobimetinib
Number of subjects: 514

Group type: COMPARATOR
Intervention: Control (placebo plus vemurafenib plus cobimetinib)
Number of subjects: 514
Study: 34053786

Group type: EXPERIMENTAL
Intervention: Digital Breast Tomosynthesis (DBT)
Number of subjects: 28749

Group type: COMPARATOR
Intervention: Digital Mammography (DM)
Number of subjects: 28749
Study: 32887873

Group type: EXPERIMENTAL
Intervention: Elotuzumab plus lenalidomide/dexamethasone (ERd)
Number of subjects: 646

Group type: COMPARATOR
Intervention: Lenalidomide/dexamethasone (Rd)
Number of subjects: 646
Study: 35683359

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.6 µg/kg/h)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups (Dexmedetomidine and Control)
Number of subjects: 80
Study: 36191176

Group type: EXPERIMENTAL
Intervention: Mobile mental health apps (4 different apps used for 4 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Using the app at least once a week
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control app (most usable)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mobile mental health apps
Number of subjects: 0
Study: 33956802

Group type: EXPERIMENTAL
Intervention: 99DOTS-based treatment supervision
Number of subjects: 1913

Group type: COMPARATOR
Intervention: Routine treatment supervision (control)
Number of subjects: 1913
Study: 32285723

Group type: COMPARATOR
Intervention: Hospitals with an absolute volume of 22-36 PKRs per year
Number of subjects: 18134

Group type: COMPARATOR
Intervention: Hospitals with an absolute volume of 36-58 PKRs per year
Number of subjects: 18134

Group type: COMPARATOR
Intervention: Hospitals with more than 58 PKRs per year
Number of subjects: 18134

Group type: EXPERIMENTAL
Intervention: Hospitals with fewer than 22 PKRs per year
Number of subjects: 18134
Study: 33904665

Group type: EXPERIMENTAL
Intervention: Interactive music therapy (using small percussive instruments, guitar, voice, and recorder) applied individually before baseline ultrasound scan, oocyte pick-up, and embryo transfer.
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Interactive music therapy
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control Group (no intervention)
Number of subjects: 113
Study: 34032852

Group type: EXPERIMENTAL
Intervention: Nontasters
Number of subjects: 1935

Group type: COMPARATOR
Intervention: Supertasters
Number of subjects: 1935

Group type: COMPARATOR
Intervention: Tasters
Number of subjects: 1935
Study: 35286456

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 41

Group type: COMPARATOR
Intervention: Tacrolimus
Number of subjects: 41
Study: 33109386

Group type: EXPERIMENTAL
Intervention: Hetrombopag 7.5-mg tablets administered with high-fat, high-calorie food
Number of subjects: 12

Group type: COMPARATOR
Intervention: Hetrombopag 7.5-mg tablets administered in the fasted state
Number of subjects: 12
Study: 35945292

Group type: EXPERIMENTAL
Intervention: Flowcharts for periodontal diagnosis
Number of subjects: 152

Group type: COMPARATOR
Intervention: Consensus reports
Number of subjects: 152
Study: 34287856

Group type: EXPERIMENTAL
Intervention: Parenteral anticoagulation therapy (PACT)
Number of subjects: 8845
Study: 33160812

Group type: EXPERIMENTAL
Intervention: Monitoring (education intervention plus mobile self-monitoring with email feedback)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combined (education and monitoring interventions plus social cognitive theory-based behavioral videos)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Education (educational videos and handouts)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Overall mHealth programs
Number of subjects: 40
Study: 33347677

Group type: EXPERIMENTAL
Intervention: IVIg (2 g/kg over 4 days)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: IVIg
Number of subjects: 50
Study: 33151749

Group type: EXPERIMENTAL
Intervention: Circuit Resistance Training (CRT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40